Leishmania-infected MHC class IIhigh dendritic cells polarize CD4+ T cells toward a nonprotective T-bet+ IFN-γ+ IL-10+ phenotype

Journal of Immunology

Volumn 191, Issue 1, 2013, Pages 262-273

  Resende, Mariana ^a   Moreira, Diana ^a   Augusto, Jorge ^a   Cunha, Joana ^a,b   Neves, Bruno ^c,d   Cruz, Maria Teresa ^c   Estaquier, Jérôme ^e,f   Cordeiro da Silva, Anabela ^a,g   Silvestre, Ricardo ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF AVEIRO   (Portugal)

^e CNRS   (France)

^f LAVAL UNIVERSITY   (Canada)

^g UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR T BET;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL POLARITY; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; EX VIVO STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; LEISHMANIA INFANTUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VISCERAL LEISHMANIASIS;

ANIMALS; CELL POLARITY; CELLS, CULTURED; CHRONIC DISEASE; COCULTURE TECHNIQUES; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-10; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MICE; MICE, INBRED BALB C; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES;

EID: 84879675210     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203518     Document Type: Article

References (46)

1. Kaye, P., and P. Scott. 2011. Leishmaniasis: complexity at the host-pathogen interface. Nat. Rev. Microbiol. 9: 604-615.
2. Karp, C. L., S. H. el-Safi, T. A. Wynn, M. M. Satti, A. M. Kordofani, F. A. Hashim, M. Hag-Ali, F. A. Neva, T. B. Nutman, and D. L. Sacks. 1993. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J. Clin. Invest. 91: 1644-1648. (Pubitemid 23127368)
3. Ghalib, H. W., M. R. Piuvezam, Y. A. Skeiky, M. Siddig, F. A. Hashim, A. M. el-Hassan, D. M. Russo, and S. G. Reed. 1993. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J. Clin. Invest. 92: 324-329. (Pubitemid 23209013)
4. Murray, H. W., C. M. Lu, S. Mauze, S. Freeman, A. L. Moreira, G. Kaplan, and R. L. Coffman. 2002. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70: 6284-6293. (Pubitemid 35192720)
5. Murray, H.W., A. L. Moreira, C. M. Lu, J. L. DeVecchio, M. Matsuhashi, X. Ma, and F. P. Heinzel. 2003. Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J. Infect. Dis. 188: 458-464. (Pubitemid 36960658)
6. O'Garra, A., and P. Vieira. 2007. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7: 425-428. (Pubitemid 46834852)
7. Anderson, C. F., M. Oukka, V. J. Kuchroo, and D. Sacks. 2007. CD4(+)CD25(-) Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204: 285-297. (Pubitemid 46294545)
8. Freitas do Rosário, A. P., T. Lamb, P. Spence, R. Stephens, A. Lang, A. Roers, W. Muller, A. O'Garra, and J. Langhorne. 2012. IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection. J. Immunol. 188: 1178-1190.
9. Jankovic, D., M. C. Kullberg, C. G. Feng, R. S. Goldszmid, C. M. Collazo, M. Wilson, T. A. Wynn, M. Kamanaka, R. A. Flavell, and A. Sher. 2007. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204: 273-283. (Pubitemid 46294544)
10. + cell populations during visceral leishmaniasis. PLoS Pathog. 8: e1002827.
11. Stäger, S., A. Maroof, S. Zubairi, S. L. Sanos, M. Kopf, and P. M. Kaye. 2006. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur. J. Immunol. 36: 1764-1771.
12. Jankovic, D., D. G. Kugler, and A. Sher. 2010. IL-10 production by CD4+ effector T cells: a mechanism for self-regulation. Mucosal Immunol. 3: 239-246.
13. Khan, N., U. Gowthaman, S. Pahari, and J. N. Agrewala. 2012. Manipulation of costimulatory molecules by intracellular pathogens: veni, vidi, vici!! PLoS Pathog. 8: e1002676.
14. Carvalho, L. P., E. J. Pearce, and P. Scott. 2008. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. J. Immunol. 181: 6473-6480.
15. Moreira, D., N. Santarém, I. Loureiro, J. Tavares, A. M. Silva, A. M. Amorim, A. Ouaissi, A. Cordeiro-da-Silva, and R. Silvestre. 2012. Impact of continuous axenic cultivation in Leishmania infantum virulence. PLoS Negl. Trop. Dis. 6: e1469.
16. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
17. Neves, B. M., R. Silvestre, M. Resende, A. Ouaissi, J. Cunha, J. Tavares, I. Loureiro, N. Santarém, A. M. Silva, M. C. Lopes, et al. 2010. Activation of phosphatidylinositol 3-kinase/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation/activation state of Leishmania infantum-infected dendritic cells. Am. J. Pathol. 177: 2898-2911.
18. Kalupahana, R. S., P. Mastroeni, D. Maskell, and B. A. Blacklaws. 2005. Activation of murine dendritic cells and macrophages induced by Salmonella enterica serovar Typhimurium. Immunology 115: 462-472. (Pubitemid 41032434)
19. Silvestre, R., A. Cordeiro-Da-Silva, N. Santarém, B. Vergnes, D. Sereno, and A. Ouaissi. 2007. SIR2-deficient Leishmania infantum induces a defined IFN-gamma/IL-10 pattern that correlates with protection. J. Immunol. 179: 3161-3170.
20. Mathew, S., Y. C. Lim, and A. Kishen. 2008. Quenching of fluorescence by crystal violet and its use to differentiate between surface-bound and internalized bacteria. Proc. SPIE 6791, Saratov Fall Meeting 2007: Optical Technologies in Biophysics and Medicine IX, 67910C.
21. Masurier, C., C. Pioche-Durieu, B. M. Colombo, R. Lacave, F. M. Lemoine, D. Klatzmann, and M. Guigon. 1999. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy. Immunology 96: 569-577. (Pubitemid 29179795)
22. Menges, M., T. Baumeister, S. Rössner, P. Stoitzner, N. Romani, A. Gessner, and M. B. Lutz. 2005. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 77: 535-543. (Pubitemid 40489529)
23. Nylén, S., R. Maurya, L. Eidsmo, K. D. Manandhar, S. Sundar, and D. Sacks. 2007. Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25 + (Foxp3) regulatory T cells in human visceral leishmaniasis. J. Exp. Med. 204: 805-817.
24. Pagan, A. J., N. C. Peters, A. Debrabant, F. Ribeiro-Gomes, M. Pepper, C. L. Karp, M. K. Jenkins, and D. L. Sacks. 2013. Tracking antigen-specific CD4(+) T cells throughout the course of chronic Leishmania major infection in resistant mice. Eur. J. Immunol. 43: 427-38.
25. Taga, K., H. Mostowski, and G. Tosato. 1993. Human interleukin-10 can directly inhibit T-cell growth. Blood 81: 2964-2971. (Pubitemid 23162114)
26. Ranatunga, D., C. M. Hedrich, F. Wang, D. W. McVicar, N. Nowak, T. Joshi, L. Feigenbaum, L. R. Grant, S. Stäger, and J. H. Bream. 2009. A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome. Proc. Natl. Acad. Sci. USA 106: 17123-17128.
27. Hall, A. O., D. P. Beiting, C. Tato, B. John, G. Oldenhove, C. G. Lombana, G. H. Pritchard, J. S. Silver, N. Bouladoux, J. S. Stumhofer, et al. 2012. The cytokines interleukin 27 and interferon-g promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37: 511-523.
28. Milano, S., G. Di Bella, P. D'Agostino, C. Barbera, R. Caruso, M. La Rosa, V. Ferlazzo, G. Vitale, C. La Russa, G. Gambino, et al. 2002. IL-15 in human visceral leishmaniasis caused by Leishmania infantum. Clin. Exp. Immunol. 127: 360-365. (Pubitemid 34233944)
29. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147. (Pubitemid 32060273)
30. Nandan, D., C. Camargo de Oliveira, A. Moeenrezakhanlou, M. Lopez, J. M. Silverman, J. Subek, and N. E. Reiner. 2012. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3β downstream of phosphatidylinositol-3 kinase. J. Immunol. 188: 367-378.
31. Padigel, U. M., and J. P. Farrell. 2005. Control of infection with Leishmania major in susceptible BALB/c mice lacking the common gamma-chain for FcR is associated with reduced production of IL-10 and TGF-beta by parasitized cells. J. Immunol. 174: 6340-6345. (Pubitemid 40663827)
32. Kemp, K., M. Kemp, A. Kharazmi, A. Ismail, J. A. Kurtzhals, L. Hviid, and T. G. Theander. 1999. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin. Exp. Immunol. 116: 500-504. (Pubitemid 29258102)
33. O'Garra, A., and K. M. Murphy. 2009. From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development. Nat. Immunol. 10: 929-932.
34. Hailu, A., T. van der Poll, N. Berhe, and P. A. Kager. 2004. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. Am. J. Trop. Med. Hyg. 71: 561-567. (Pubitemid 39601152)
35. Marovich, M. A., M. A. McDowell, E. K. Thomas, and T. B. Nutman. 2000. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J. Immunol. 164: 5858-5865. (Pubitemid 30389830)
36. Quinones, M., S. K. Ahuja, P. C. Melby, L. Pate, R. L. Reddick, and S. S. Ahuja. 2000. Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite. J. Exp. Med. 192: 507-516.
37. Stumhofer, J. S., J. S. Silver, A. Laurence, P. M. Porrett, T. H. Harris, L. A. Turka, M. Ernst, C. J. Saris, J. J. O'Shea, and C. A. Hunter. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8: 1363-1371. (Pubitemid 350131173)
38. Spolski, R., H. P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard. 2009. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182: 2859-2867.
39. Huss, D. J., R. C. Winger, H. Peng, Y. Yang, M. K. Racke, and A. E. Lovett-Racke. 2010. TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10. J. Immunol. 184: 5628-5636.
40. Pot, C., H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai, R. Madan, A. H. Sharpe, C. L. Karp, S. C. Miaw, I. C. Ho, and V. K. Kuchroo. 2009. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183: 797-801.
41. Ansari, N. A., R. Kumar, S. Gautam, S. Nylén, O. P. Singh, S. Sundar, and D. Sacks. 2011. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J. Immunol. 186: 3977-3985.
42. Batten, M., J. Li, S. Yi, N. M. Kljavin, D. M. Danilenko, S. Lucas, J. Lee, F. J. de Sauvage, and N. Ghilardi. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7: 929-936. (Pubitemid 44263906)
43. Brewig, N., A. Kissenpfennig, B. Malissen, A. Veit, T. Bickert, B. Fleischer, S. Mostböck, and U. Ritter. 2009. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J. Immunol. 182: 774-783.
44. León, B., M. López-Bravo, and C. Ardavín. 2007. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26: 519-531.
45. Iezzi, G., A. Fröhlich, B. Ernst, F. Ampenberger, S. Saeland, N. Glaichenhaus, and M. Kopf. 2006. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J. Immunol. 177: 1250-1256.
46. Prasad, S. J., and C. C. Goodnow. 2002. Cell-intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo. Int. Immunol. 14: 677-684. (Pubitemid 34649723) Tecnologia Tecnologia Estratégica Nacional-Tipologia 4.2-Promocão do Emprego Científico